![](/img/cover-not-exists.png)
134P Safety and efficacy of eribulin and trastuzumab in anti-HER2 therapy pretreated patients with HER2-positive metastatic breast cancer: A Japanese multicenter phase 2 study (SBP-04 study)
Shien, T., Ikeda, M., Ohtani, S., Hara, F., Takahashi, M., Tuji, H., Yoshitomi, S., Matsuoka, K., Ogasawara, Y., Taira, N., Doihara, H., Ohsumi, S.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw577.017
Date:
December, 2016
File:
PDF, 55 KB
english, 2016